Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02526004Completed
Randomised, open-label trial in cystic fibrosis (CF) (2 arms), sponsored by University College Cork. Primary endpoint: Percentage change in recovery FEV1 relative to previous pre-exacerbation FEV1 at 14 days. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02526004.